Kv1.3 voltage gated potassium ion channel inhibitors (UCB)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameKv1.3 voltage gated potassium ion channel inhibitors (UCB)
Drug Alias NameKv1.3 voltage gated potassium ion channel inhibitors (Lectus Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.3 blockers
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLectus Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLectus Therapeutics LtdUcb Sa
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A